Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations

International Journal of Colorectal Disease

Volumn 29, Issue 10, 2014, Pages 1223-1229

  Perrakis, Aristotelis ^a   Weber, Klaus ^a   Merkel, Susanne ^a   Matzel, Klaus ^a   Agaimy, Abbas ^a   Gebbert, Carol ^a   Hohenberger, Werner ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Colon carcinoma; Hepatic flexure; Lymph node; Splenic flexure; Surgery; Transverse colon

Indexed keywords

ADULT; AGED; CANCER STAGING; COLONIC NEOPLASMS; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MESOCOLON; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; TRANSVERSE COLON; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLON, TRANSVERSE; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MESOCOLON; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84929132201     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-014-1971-2     Document Type: Article

References (28)

1. Hohenberger W, Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Color Dis 11:354–364
2. Weber K, Merkel S, Perrakis A, Hohenberger W (2013) Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Color Dis 28(2):217–226
3. West NP, Hohenberger W, Weber K et al (2010) Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 28:272–278
4. West NP, Kobayashi H, Takahashi K et al (2012) Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30(15):1763–1769
5. Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery — the clue to pelvic recurrence? Br J Surg 69:613–616
6. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 327:1479–1482
7. Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node positive rectal cancer. Dis Colon Rectum 47:1145–1150
8. Nagtegaal ID, van de Velde CJH, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734
9. Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828
10. Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602–610
11. Johnson PM, Porter GA, Ricciardi R, Baxter NN (2006) Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24:3570–3575
12. Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T (2007) The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 194:827–832
13. Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919
14. Mammen JM, James LE, Molloy M, Williams A et al (2007) The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 194:349–354
15. Toyota S, Ohta H, Anazawa S (1995) Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum 38:705–711
16. Jass JR, Sobin LH (1989) Histological classification of tumours, 2nd ed. WHO international histological classification of tumours. Springer, Berlin
17. Sobin LH, Gospodarowicz M, Wittekind C (2009) UICC TNM classification of malignant tumors, 7th edn. John Wiley & Sons, New York
18. Cancer Res UK. Cancer Stats. http://info.cancerresearchuk.org/cancerstats/types/bowel/
19. American Cancer Society: Cancer Facts and Figures (2009) http://www.cancer.org/docroot/STT/STT_0.asp
20. Koyama Y, Kotake K (1997) Overview of colorectal cancer in Japan: report from the Registry of the Japanese Society for Cancer of the Colon and Rectum. Dis Colon Rectum 40(suppl):S2–S9
21. International Agency for Research on Cancer, World Health Organization: GLOBOCAN (2008) Cancer Incidence and Mortality Worldwide in 2008. http://globocan.iarc.fr/
22. Heald RJ (1988) The ‘Holy Plane’ of rectal surgery. J R Soc Med 81:503–508
23. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
24. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123
25. Folkesson J, Birgisson H, Pahlman L et al (2005) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644–5650
26. Taal BG, Van Tinteren H, Zoetmulder FA (2001) NACCP group Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 85:1437–1443
27. André T, Boni C, Mounedji-Boudiaf L et al (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351
28. Link KH, Kornmann M, Staib L et al (2005) Study Group Oncology of Gastrointestinal Tumors Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha. Ann Surg 242:178–187